MCUJF: An interesting find, ronpopeil. Can you provide any details of your investigation(s) on the co., AGGRASTAT, or their development drug(s) that you think make for a compelling investment opportunity here. I did a cursory search and cannot find whether or not AGGRASTAT is patent protected and/or how long it will be. The drug appears to have been around for some time. One study (2001) of head to head comparison with another Platelet Glycoprotein IIb/IIIa Inhibitor found that AGGRASTST was inferior to the compared medication (abciximab), even though the study was designed for simple non-inferiority.
News 
Market Data 
Discover 
